CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF)
CANOPY GROWTH CORP COM NPV(OTCMKTS:TWMJF) is a cannabis grower and processor based in Ontario, Canada. The company trades on the American OTCMKTS under the ticker TWMJF and on the Toronto Exchange under the ticker WEED. The company has three brands under its umbrella – Tweed, Bedrocan, and Mettrum.
Tweed is the most identifiable brand owned by CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF). The company claims the Tweed brand is the most recognized marijuana production brand in the world that has cultivated a following by providing a high quality product and nurturing customer relationships.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) also owns the Bedrocan brand of medical-grade cannabis. The strain was pioneered in the Netherlands and the company jas exclusive licensing rights for Canada and the United States. What is noteworthy is that the Bedrocan strain of cannabis has been used in clinical research in seven different EU countries. Currently the strain is being evaluated in Canada in a clinical study named EQUAL to evaluate quality of life factors before and after cannabis use.
Mettrum is a Health Canada licensed producer of medical cannabis and cannabis products. The company has also developed a color-based dosage system and physician online portal. CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) positions the Mettrum brand as a health and wellness product which is positioned between Tweed, a cannabis brand for social use, and Bedrocan, a cannabis targeted for use in the medical field.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) has either purchased outright or taken a material position in nine other companies operating in Canada’s cannabis sector. They have fomed partnerships with Snoop Dog, DNA Genetics, AusCann, and Indoor Harvest. For FY2016 the company had total assets of C$280 million and total liabilities of C$29.1 million.
CANOPY GROWTH CORP COM NPV (OTCMKTS:TWMJF) estimates the harvest yields for the plants at various stages of growth. As of December 31, 2016, it is expected that the company’s biological assets will yield approximately 3,129 kg compared to 2,121 kg at March 31, 2016.
I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.
About the author: Marc has a degree in economics and a MSc. in Finance. Over his 20-year career, Marc has worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.